-
1
-
-
0036729478
-
Cyclic nucleotide research - still expanding after half a century
-
Beavo JA, Brunton LL, (2002) Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol 3: 710-718.
-
(2002)
Nat Rev Mol Cell Biol
, vol.3
, pp. 710-718
-
-
Beavo, J.A.1
Brunton, L.L.2
-
2
-
-
56349152612
-
Regulation and function of cyclic GMP-mediated pathways in glial cells
-
Baltrons MA, Boran MS, Pifarre P, Garcia A, (2008) Regulation and function of cyclic GMP-mediated pathways in glial cells. Neurochem Res 33: 2427-2435.
-
(2008)
Neurochem Res
, vol.33
, pp. 2427-2435
-
-
Baltrons, M.A.1
Boran, M.S.2
Pifarre, P.3
Garcia, A.4
-
3
-
-
77955089959
-
CXCR4-mediated glutamate exocytosis from astrocytes
-
Cali C, Bezzi P, (2010) CXCR4-mediated glutamate exocytosis from astrocytes. J Neuroimmunol 224: 13-21.
-
(2010)
J Neuroimmunol
, vol.224
, pp. 13-21
-
-
Cali, C.1
Bezzi, P.2
-
4
-
-
50449099017
-
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms
-
Giorgi M, D'Angelo V, Esposito Z, Nuccetelli V, Sorge R, et al. (2008) Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci 28: 941-950.
-
(2008)
Eur J Neurosci
, vol.28
, pp. 941-950
-
-
Giorgi, M.1
D'Angelo, V.2
Esposito, Z.3
Nuccetelli, V.4
Sorge, R.5
-
5
-
-
0027742932
-
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease
-
Hossain MA, Weiner N, (1993) Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease. J Pharmacol Exp Ther 267: 1105-1111.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, pp. 1105-1111
-
-
Hossain, M.A.1
Weiner, N.2
-
6
-
-
0033573697
-
Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels
-
Aguila MC, Kuljis RO, (1999) Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels. Brain Res 816: 241-244.
-
(1999)
Brain Res
, vol.816
, pp. 241-244
-
-
Aguila, M.C.1
Kuljis, R.O.2
-
7
-
-
0035978743
-
Amyotrophic lateral sclerosis
-
Rowland LP, Shneider NA, (2001) Amyotrophic lateral sclerosis. N Engl J Med 344: 1688-1700.
-
(2001)
N Engl J Med
, vol.344
, pp. 1688-1700
-
-
Rowland, L.P.1
Shneider, N.A.2
-
8
-
-
9744227184
-
Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains
-
Baltrons MA, Pifarre P, Ferrer I, Carot JM, Garcia A, (2004) Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains. Neurobiol Dis 17: 462-472.
-
(2004)
Neurobiol Dis
, vol.17
, pp. 462-472
-
-
Baltrons, M.A.1
Pifarre, P.2
Ferrer, I.3
Carot, J.M.4
Garcia, A.5
-
9
-
-
62549126072
-
Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy
-
Dupiereux I, Zorzi W, Quadrio I, Perret-Liaudet A, Kovacs GG, et al. (2009) Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy. Cent Nerv Syst Agents Med Chem 9: 2-11.
-
(2009)
Cent Nerv Syst Agents Med Chem
, vol.9
, pp. 2-11
-
-
Dupiereux, I.1
Zorzi, W.2
Quadrio, I.3
Perret-Liaudet, A.4
Kovacs, G.G.5
-
10
-
-
57149120501
-
Biomarkers in amyotrophic lateral sclerosis
-
Turner MR, Kiernan MC, Leigh PN, Talbot K, (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8: 94-109.
-
(2009)
Lancet Neurol
, vol.8
, pp. 94-109
-
-
Turner, M.R.1
Kiernan, M.C.2
Leigh, P.N.3
Talbot, K.4
-
11
-
-
0035100888
-
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
-
Biomarkers Definitions Working Group
-
Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 89-95
-
-
-
12
-
-
79959856349
-
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
-
Jesse S, Brettschneider J, Sussmuth SD, Landwehrmeyer BG, von Arnim CA, et al. (2011) Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol 258: 1034-1041.
-
(2011)
J Neurol
, vol.258
, pp. 1034-1041
-
-
Jesse, S.1
Brettschneider, J.2
Sussmuth, S.D.3
Landwehrmeyer, B.G.4
von Arnim, C.A.5
-
13
-
-
77958065565
-
Problems associated with fluid biomarkers for Parkinson's disease
-
Nyhlen J, Constantinescu R, Zetterberg H, (2010) Problems associated with fluid biomarkers for Parkinson's disease. Biomark Med 4: 671-681.
-
(2010)
Biomark Med
, vol.4
, pp. 671-681
-
-
Nyhlen, J.1
Constantinescu, R.2
Zetterberg, H.3
-
14
-
-
65549111767
-
Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review
-
Jesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, et al. (2009) Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci Ther 15: 157-182.
-
(2009)
CNS Neurosci Ther
, vol.15
, pp. 157-182
-
-
Jesse, S.1
Steinacker, P.2
Lehnert, S.3
Gillardon, F.4
Hengerer, B.5
-
15
-
-
79951720856
-
alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
-
Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, et al. (2011) alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10: 230-240.
-
(2011)
Lancet Neurol
, vol.10
, pp. 230-240
-
-
Mollenhauer, B.1
Locascio, J.J.2
Schulz-Schaeffer, W.3
Sixel-Doring, F.4
Trenkwalder, C.5
-
16
-
-
33645800776
-
Axonal damage markers in cerebrospinal fluid are increased in ALS
-
Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H, (2006) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66: 852-856.
-
(2006)
Neurology
, vol.66
, pp. 852-856
-
-
Brettschneider, J.1
Petzold, A.2
Sussmuth, S.D.3
Ludolph, A.C.4
Tumani, H.5
-
17
-
-
33947574116
-
Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis
-
Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H, (2007) Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci Lett 416: 257-260.
-
(2007)
Neurosci Lett
, vol.416
, pp. 257-260
-
-
Brettschneider, J.1
Widl, K.2
Schattauer, D.3
Ludolph, A.C.4
Tumani, H.5
-
19
-
-
0037709838
-
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
-
Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, et al. (2003) Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 60: 813-816.
-
(2003)
Arch Neurol
, vol.60
, pp. 813-816
-
-
Geschwind, M.D.1
Martindale, J.2
Miller, D.3
DeArmond, S.J.4
Uyehara-Lock, J.5
-
20
-
-
0037154135
-
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
-
Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, et al. (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58: 192-197.
-
(2002)
Neurology
, vol.58
, pp. 192-197
-
-
Otto, M.1
Wiltfang, J.2
Cepek, L.3
Neumann, M.4
Mollenhauer, B.5
-
21
-
-
78650671552
-
ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients
-
Steinacker P, Klafki H, Lehnert S, Jesse S, Arnim CA, et al. (2010) ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. J Alzheimers Dis 22: 119-128.
-
(2010)
J Alzheimers Dis
, vol.22
, pp. 119-128
-
-
Steinacker, P.1
Klafki, H.2
Lehnert, S.3
Jesse, S.4
Arnim, C.A.5
-
22
-
-
73549105915
-
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease
-
Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, et al. (2010) Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics 10: 81-89.
-
(2010)
Proteomics
, vol.10
, pp. 81-89
-
-
Steinacker, P.1
Rist, W.2
Swiatek-de-Lange, M.3
Lehnert, S.4
Jesse, S.5
-
23
-
-
79751535822
-
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
-
Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, et al. (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17: 175-178.
-
(2011)
Nat Med
, vol.17
, pp. 175-178
-
-
Atarashi, R.1
Satoh, K.2
Sano, K.3
Fuse, T.4
Yamaguchi, N.5
-
24
-
-
36649029701
-
Peirce, Youden, and Receiver Operating Characteristic Curves
-
Baker SG, Kramer BS, (2007) Peirce, Youden, and Receiver Operating Characteristic Curves. Am Stat 61: 343-346.
-
(2007)
Am Stat
, vol.61
, pp. 343-346
-
-
Baker, S.G.1
Kramer, B.S.2
-
25
-
-
10744219944
-
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study
-
Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, et al. (2004) Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology 62: 714-718.
-
(2004)
Neurology
, vol.62
, pp. 714-718
-
-
Otto, M.1
Cepek, L.2
Ratzka, P.3
Doehlinger, S.4
Boekhoff, I.5
-
26
-
-
0006164301
-
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop
-
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124.
-
(1996)
Neurology
, vol.47
, pp. 1113-1124
-
-
McKeith, I.G.1
Galasko, D.2
Kosaka, K.3
Perry, E.K.4
Dickson, D.W.5
-
27
-
-
82055185503
-
Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue
-
Oeckl P, Ferger B, (2011) Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue. J Neurosci Methods 203: 338-343.
-
(2011)
J Neurosci Methods
, vol.203
, pp. 338-343
-
-
Oeckl, P.1
Ferger, B.2
-
28
-
-
0023260685
-
Cyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients
-
Covickovic-Sternic N, Kostic VS, Djuricic BM, Bumbasirevic-Beslac L, Nikolic M, et al. (1987) Cyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients. Eur Neurol 27: 24-28.
-
(1987)
Eur Neurol
, vol.27
, pp. 24-28
-
-
Covickovic-Sternic, N.1
Kostic, V.S.2
Djuricic, B.M.3
Bumbasirevic-Beslac, L.4
Nikolic, M.5
-
29
-
-
0021309291
-
Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders
-
Cramer H, Warter JM, Renaud B, (1984) Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders. Adv Neurol 40: 431-435.
-
(1984)
Adv Neurol
, vol.40
, pp. 431-435
-
-
Cramer, H.1
Warter, J.M.2
Renaud, B.3
-
30
-
-
0029003713
-
Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases
-
Ikeda M, Sato I, Yuasa T, Miyatake T, Murota S, (1995) Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases. J Neural Transm Gen Sect 100: 263-267.
-
(1995)
J Neural Transm Gen Sect
, vol.100
, pp. 263-267
-
-
Ikeda, M.1
Sato, I.2
Yuasa, T.3
Miyatake, T.4
Murota, S.5
-
31
-
-
0019476341
-
Cyclic adenosine 3′,5′ monophosphate in cerebrospinal fluid of multiple sclerosis patients
-
Maida E, Kristoferitsch W, (1981) Cyclic adenosine 3′,5′ monophosphate in cerebrospinal fluid of multiple sclerosis patients. J Neurol 225: 145-151.
-
(1981)
J Neurol
, vol.225
, pp. 145-151
-
-
Maida, E.1
Kristoferitsch, W.2
-
32
-
-
0017033455
-
Studies on cyclic AMP in different compartments of cerebrospinal fluid
-
Tsang D, Lal S, Sourkes TL, Ford RM, Aronoff A, (1976) Studies on cyclic AMP in different compartments of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 39: 1186-1190.
-
(1976)
J Neurol Neurosurg Psychiatry
, vol.39
, pp. 1186-1190
-
-
Tsang, D.1
Lal, S.2
Sourkes, T.L.3
Ford, R.M.4
Aronoff, A.5
-
33
-
-
0015698643
-
Adenosine 3′,5′-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease
-
Cramer H, Ng LK, Chase TN, (1973) Adenosine 3′,5′-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease. Arch Neurol 29: 197-199.
-
(1973)
Arch Neurol
, vol.29
, pp. 197-199
-
-
Cramer, H.1
Ng, L.K.2
Chase, T.N.3
-
34
-
-
58949095596
-
Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3′,5′-monophosphate (cGMP) in clinical applications: a comparison with a EIA method
-
Zhang Y, Dufield D, Klover J, Li W, Szekely-Klepser G, et al. (2009) Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3′,5′-monophosphate (cGMP) in clinical applications: a comparison with a EIA method. J Chromatogr B Analyt Technol Biomed Life Sci 877: 513-520.
-
(2009)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.877
, pp. 513-520
-
-
Zhang, Y.1
Dufield, D.2
Klover, J.3
Li, W.4
Szekely-Klepser, G.5
-
35
-
-
0345055825
-
Cerebrospinal fluid cyclic guanosine 3′5′ monophosphate levels in Parkinson's disease
-
Navarro JA, Jimenez-Jimenez FJ, Molina JA, ito-Leon J, Cisneros E, et al. (1998) Cerebrospinal fluid cyclic guanosine 3′5′ monophosphate levels in Parkinson's disease. J Neurol Sci 155: 92-94.
-
(1998)
J Neurol Sci
, vol.155
, pp. 92-94
-
-
Navarro, J.A.1
Jimenez-Jimenez, F.J.2
Molina, J.A.3
ito-Leon, J.4
Cisneros, E.5
-
36
-
-
0022657676
-
CSF cyclic nucleotides and somatostatin in Parkinson's disease
-
Volicer L, Beal MF, Direnfeld LK, Marquis JK, Albert ML, (1986) CSF cyclic nucleotides and somatostatin in Parkinson's disease. Neurology 36: 89-92.
-
(1986)
Neurology
, vol.36
, pp. 89-92
-
-
Volicer, L.1
Beal, M.F.2
Direnfeld, L.K.3
Marquis, J.K.4
Albert, M.L.5
-
37
-
-
0018100483
-
The effect of L-dopa and propranolol on human CSF cyclic nucleotides
-
Belmaker RH, Ebstein RP, Biederman J, Stern R, Berman M, et al. (1978) The effect of L-dopa and propranolol on human CSF cyclic nucleotides. Psychopharmacology (Berl) 58: 307-310.
-
(1978)
Psychopharmacology (Berl)
, vol.58
, pp. 307-310
-
-
Belmaker, R.H.1
Ebstein, R.P.2
Biederman, J.3
Stern, R.4
Berman, M.5
-
38
-
-
76749084276
-
Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF
-
Torremans A, Van HA, Straetemans R, Vanhoof G, Van Den KG, et al. (2010) Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF. Brain Res Bull 81: 549-551.
-
(2010)
Brain Res Bull
, vol.81
, pp. 549-551
-
-
Torremans, A.1
van, H.A.2
Straetemans, R.3
Vanhoof, G.4
van Den, K.G.5
-
39
-
-
0344994681
-
Increased cerebrospinal fluid cAMP levels in Alzheimer's disease
-
Martinez M, Fernandez E, Frank A, Guaza C, de la FM, et al. (1999) Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res 846: 265-267.
-
(1999)
Brain Res
, vol.846
, pp. 265-267
-
-
Martinez, M.1
Fernandez, E.2
Frank, A.3
Guaza, C.4
de la, F.M.5
-
40
-
-
0019455113
-
CSF Vasopressin and cyclic nucleotide concentrations in senile dementia
-
Tsuji M, Takahashi S, Akazawa S, (1981) CSF Vasopressin and cyclic nucleotide concentrations in senile dementia. Psychoneuroendocrinology 6: 171-176.
-
(1981)
Psychoneuroendocrinology
, vol.6
, pp. 171-176
-
-
Tsuji, M.1
Takahashi, S.2
Akazawa, S.3
-
41
-
-
0022376119
-
Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type
-
Volicer L, Direnfeld LK, Langlais PJ, Freedman M, Bird ED, et al. (1985) Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type. J Gerontol 40: 708-713.
-
(1985)
J Gerontol
, vol.40
, pp. 708-713
-
-
Volicer, L.1
Direnfeld, L.K.2
Langlais, P.J.3
Freedman, M.4
Bird, E.D.5
-
42
-
-
10744228025
-
Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis
-
Ilzecka J, (2004) Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis. J Neural Transm 111: 167-172.
-
(2004)
J Neural Transm
, vol.111
, pp. 167-172
-
-
Ilzecka, J.1
-
43
-
-
77953340215
-
Prion diseases
-
Venneti S, (2010) Prion diseases. Clin Lab Med 30: 293-309.
-
(2010)
Clin Lab Med
, vol.30
, pp. 293-309
-
-
Venneti, S.1
-
44
-
-
0019811050
-
Plasma cyclic nucleotide levels in exercise-induced asthma
-
Hartley JP, Davies CJ, Charles TJ, Monie RD, Nogrady SG, et al. (1981) Plasma cyclic nucleotide levels in exercise-induced asthma. Thorax 36: 823-827.
-
(1981)
Thorax
, vol.36
, pp. 823-827
-
-
Hartley, J.P.1
Davies, C.J.2
Charles, T.J.3
Monie, R.D.4
Nogrady, S.G.5
-
45
-
-
0033849497
-
An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients
-
Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, et al. (2000) An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 48: 395-398.
-
(2000)
Ann Neurol
, vol.48
, pp. 395-398
-
-
Kenney, K.1
Brechtel, C.2
Takahashi, H.3
Kurohara, K.4
Anderson, P.5
-
46
-
-
9844234269
-
S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
-
Otto M, Stein H, Szudra A, Zerr I, Bodemer, et al. (1997) S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 244: 566-570.
-
(1997)
J Neurol
, vol.244
, pp. 566-570
-
-
Otto, M.1
Stein, H.2
Szudra, A.3
Zerr, I.4
Bodemer5
-
47
-
-
79952400329
-
Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
-
Singh A, Beveridge AJ, Singh N, (2011) Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders. PLoS One 6: e16804.
-
(2011)
PLoS One
, vol.6
-
-
Singh, A.1
Beveridge, A.J.2
Singh, N.3
|